Biological Signal Processing (BSP), a developer and commercialiser of advanced products for the non invasive, accurate diagnosis of heart diseases, has received the European CE conformance mark grant for its HyperQ AD-100, intended for improved diagnostic performance of Stress ECG.

See more here:
BSP HyperQ AD-100 Receives CE Mark